These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9003521)

  • 1. Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety.
    Lai YS; Mendoza JS; Jagdmann GE; Menaldino DS; Biggers CK; Heerding JM; Wilson JW; Hall SE; Jiang JB; Janzen WP; Ballas LM
    J Med Chem; 1997 Jan; 40(2):226-35. PubMed ID: 9003521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A.
    Defauw JM; Murphy MM; Jagdmann GE; Hu H; Lampe JW; Hollinshead SP; Mitchell TJ; Crane HM; Heerding JM; Mendoza JS; Davis JE; Darges JW; Hubbard FR; Hall SE
    J Med Chem; 1996 Dec; 39(26):5215-27. PubMed ID: 8978850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and protein kinase inhibitory activity of balanol analogues with modified benzophenone subunits.
    Lampe JW; Biggers CK; Defauw JM; Foglesong RJ; Hall SE; Heerding JM; Hollinshead SP; Hu H; Hughes PF; Jagdmann GE; Johnson MG; Lai YS; Lowden CT; Lynch MP; Mendoza JS; Murphy MM; Wilson JW; Ballas LM; Carter K; Darges JW; Davis JE; Hubbard FR; Stamper ML
    J Med Chem; 2002 Jun; 45(12):2624-43. PubMed ID: 12036372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol.
    Koide K; Bunnage ME; Gomez Paloma L; Kanter JR; Taylor SS; Brunton LL; Nicolaou KC
    Chem Biol; 1995 Sep; 2(9):601-8. PubMed ID: 9383464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and protein kinase C inhibitory activities of balanol analogues with modification of 4-hydroxybenzamido moiety.
    Hu H; Mendoza JS; Lowden CT; Ballas LM; Janzen WP
    Bioorg Med Chem; 1997 Sep; 5(9):1873-82. PubMed ID: 9354244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases.
    Hardianto A; Yusuf M; Liu F; Ranganathan S
    BMC Bioinformatics; 2017 Dec; 18(Suppl 16):572. PubMed ID: 29297286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
    Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
    Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential and selective inhibition of protein kinase A and protein kinase C in intact cells by balanol congeners.
    Gustafsson AB; Brunton LL
    Mol Pharmacol; 1999 Aug; 56(2):377-82. PubMed ID: 10419557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and target identification of hymenialdisine analogs.
    Wan Y; Hur W; Cho CY; Liu Y; Adrian FJ; Lozach O; Bach S; Mayer T; Fabbro D; Meijer L; Gray NS
    Chem Biol; 2004 Feb; 11(2):247-59. PubMed ID: 15123286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C.
    Aftab DT; Ballas LM; Loomis CR; Hait WN
    Mol Pharmacol; 1991 Nov; 40(5):798-805. PubMed ID: 1944244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correspondence analysis of protein kinase C (PKC) inhibition by bis-basic substituted benzamides.
    Gilbert J; Cheminant M; Bignon E; Pons M; Ojasoo T; Doré JC
    Drug Des Discov; 1998 Oct; 15(4):253-67. PubMed ID: 10546070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking of balanol to dynamics snapshots of protein kinase A.
    Wong CF; Kua J; Zhang Y; Straatsma TP; McCammon JA
    Proteins; 2005 Dec; 61(4):850-8. PubMed ID: 16245317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors.
    Luksch T; Chan NS; Brass S; Sotriffer CA; Klebe G; Diederich WE
    ChemMedChem; 2008 Sep; 3(9):1323-36. PubMed ID: 18752222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
    Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
    Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiral version of the Burgess reagent and its reactions with oxiranes: application to the formal enantiodivergent synthesis of balanol.
    Sullivan B; Gilmet J; Leisch H; Hudlicky T
    J Nat Prod; 2008 Mar; 71(3):346-50. PubMed ID: 18205317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based optimization of novel azepane derivatives as PKB inhibitors.
    Breitenlechner CB; Wegge T; Berillon L; Graul K; Marzenell K; Friebe WG; Thomas U; Schumacher R; Huber R; Engh RA; Masjost B
    J Med Chem; 2004 Mar; 47(6):1375-90. PubMed ID: 14998327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structure-activity relationship of new isobenzofuranone ligands of protein kinase C.
    Baba Y; Ogoshi Y; Hirai G; Yanagisawa T; Nagamatsu K; Mayumi S; Hashimoto Y; Sodeoka M
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2963-7. PubMed ID: 15125969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C intervention: the state of play.
    Roffey J; Rosse C; Linch M; Hibbert A; McDonald NQ; Parker PJ
    Curr Opin Cell Biol; 2009 Apr; 21(2):268-79. PubMed ID: 19233632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An organoiron approach to the benzophenone appendage of the protein kinase C inhibitor balanol.
    Storm JP; Andersson CM
    Org Lett; 1999 Nov; 1(9):1451-3. PubMed ID: 10825993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.